Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of DA-302168S tablets in overweight and obese subjects. The study status is active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• DA-302168S Tablets

Snippet

Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. | Conditions: Overweight and Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING